Mentho patch

Manufacturer
THE EGYPTIAN SAUDI CO FOR MEDICAL MANUFACTURING MASCOMID
Effective date
2025-10-06
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
full-release
Hydrated at
2026-06-01 01:18:38

Label at a glance#

ProductMentho patch cool
Active ingredientMENTHOL
Label structure9 sections

Dosage and administration

Adults and children 3 years of age and older: apply to affected area not more than 3 to 4 times daily. Children under 3 years of age: consult doctor.

Storage and handling

store in cool dry place avoid direct sunlight.

Label contents#

Full prescribing information#

Purpose 

OTC - PURPOSE SECTION

For the temprorary releif of minor aches and pains of musceles and joints associated with simple backache, arthritis,strainsand sprains

Warnings

WARNINGS SECTION

  • FOR EXTERNAL USE ONLY
  • When Using this Product
  • Avoid contact with eyes
  • Do not apply to open wounds, or to damaged skin
  • Do not bandage tightly.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults and children 3 years of age and older: apply to affected area not more than 3 to 4 times daily.
  • Children under 3 years of age: consult doctor.

Stop use and ask doctor

OTC - ASK DOCTOR SECTION

  • If condition worsens
  • If symptoms persist more than 7 days or clear up and occur again with a few days

storage

STORAGE AND HANDLING SECTION

  • store in cool dry place avoid direct sunlight.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away

Active ingridient section

OTC - ACTIVE INGREDIENT SECTION

Menthol,Camphor,Methyl salicylate

INACTIVE INGREDIENT SECTION

Glycerin ,Sodium poly acryl ate ,Aluminum chloride hex hydrate 2 ,
Anhydrous citric acid ,Tartaric acid 1 ,Poly sorbate -80 (tween 80) 0.5 ,Isopropyl myristate alcohol 2.5 ,Car boxy methyl cellulose (CMC) 2 
EDETA 0.5 ,Polyvinyl pyrolidone(PVP-K90) 3 ,Water 48.35 ,titanium dioxide 0.05,ACRYLATE/ C10-30 ALKYL ACRYLATE,cross polymer

Product label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage descriptionimage descriptionimage description

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72602-002-012021-12-08C16284748780-1ba0f9c33-4206-a910-e053-dadaa90a0b85Menthopatch Cool
72602-002-012021-01-29C16284748780-1ba0f9c33-4206-a910-e053-dadaa90a0b85Menthopatch Cool

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72602-002-01Mentho patchcool10 g in 1 PATCHPATCH107

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72602-00272602-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Mentho patch coolMENTHOLTHE EGYPTIAN SAUDI CO FOR MEDICAL MANUFACTURING MASCOMID02251a4a-fc6f-42c9-a244-6f4835de5edd2025-10-06WarningsExact identifier
ndc (package): 72602-002-01
ndc (product): 72602-002
ndc11 (package): 72602000201
spl id: 4081693b-163f-bdea-e063-6294a90ad290
spl set id: 02251a4a-fc6f-42c9-a244-6f4835de5edd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.